| Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ... Viruses 11 (8), 762, 2019 | 447 | 2019 |
| Immunomodulatory effects of vitamin D in pregnancy and beyond F Cyprian, E Lefkou, K Varoudi, G Girardi Frontiers in immunology 10, 2739, 2019 | 170 | 2019 |
| Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: a new clinical paradigm in the treatment of triple-negative breast cancer FS Cyprian, S Akhtar, Z Gatalica, S Vranic Bosnian Journal of Basic Medical Sciences 19 (3), 227, 2019 | 116 | 2019 |
| iNKT cell development is orchestrated by different branches of TGF-β signaling JM Doisne, L Bartholin, KP Yan, CN Garcia, N Duarte, JB Le Luduec, ... Journal of Experimental Medicine 206 (6), 1365-1378, 2009 | 113 | 2009 |
| PD-L1 status in breast cancer: current view and perspectives S Vranic, FS Cyprian, Z Gatalica, J Palazzo Seminars in cancer biology 72, 146-154, 2021 | 103 | 2021 |
| Modulation of DNA damage response and induction of apoptosis mediates synergism between doxorubicin and a new imidazopyridine derivative in breast and lung cancer cells RA El-Awady, MH Semreen, MM Saber-Ayad, F Cyprian, V Menon, ... DNA repair 37, 1-11, 2016 | 75 | 2016 |
| Epstein–Barr virus and human papillomaviruses interactions and their roles in the initiation of epithelial–mesenchymal transition and cancer progression FS Cyprian, HF Al-Farsi, S Vranic, S Akhtar, AE Al Moustafa Frontiers in Oncology 8, 111, 2018 | 59 | 2018 |
| Epstein–Barr virus in gliomas: cause, association, or artifact? S Akhtar, S Vranic, FS Cyprian, AE Al Moustafa Frontiers in oncology 8, 123, 2018 | 58 | 2018 |
| The role of epstein–barr virus in cervical cancer: a brief update S Vranic, FS Cyprian, S Akhtar, AE Al Moustafa Frontiers in oncology 8, 113, 2018 | 54 | 2018 |
| Generation of mice with conditionally activated transforming growth factor beta signaling through the TβRI/ALK5 receptor L Bartholin, FS Cyprian, D Vincent, CN Garcia, S Martel, B Horvat, ... genesis 46 (12), 724-731, 2008 | 52 | 2008 |
| SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections F Cyprian, MU Sohail, I Abdelhafez, S Salman, Z Attique, L Kamareddine, ... International Journal of Infectious Diseases 105, 540-550, 2021 | 42 | 2021 |
| Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer D Elkhalifa, AB Siddique, M Qusa, FS Cyprian, K El Sayed, F Alali, ... European Journal of Medicinal Chemistry 187, 111954, 2020 | 42 | 2020 |
| The prevalence of adaptive immunity to COVID-19 and reinfection after recovery–a comprehensive systematic review and meta-analysis T Chivese, JT Matizanadzo, OAH Musa, G Hindy, L Furuya-Kanamori, ... Pathogens and global health 116 (5), 269-281, 2022 | 38 | 2022 |
| Cytokine responses in campylobacteriosis: Linking pathogenesis to immunity NA Al-Banna, F Cyprian, MJ Albert Cytokine & growth factor reviews 41, 75-87, 2018 | 33 | 2018 |
| Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019; 11 (8): 762 MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ... | 28 | 2019 |
| Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment V Sasidharan Nair, R Saleh, SM Toor, FS Cyprian, E Elkord Cancer immunology, immunotherapy 70, 2103-2121, 2021 | 27 | 2021 |
| SnoRNAs and miRNAs networks underlying COVID-19 disease severity A Parray, FA Mir, A Doudin, A Iskandarani, IMM Danjuma, RAT Kuni, ... Vaccines 9 (10), 1056, 2021 | 24 | 2021 |
| Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis S Thomas, MK Smatti, A Ouhtit, FS Cyprian, MA Almaslamani, A Al Thani, ... Molecular Immunology 152, 172-182, 2022 | 21 | 2022 |
| Development of oral cancer AE Al Moustafa Risk Factors and Prevention Strategies. Doha 10, 978-3, 2017 | 21 | 2017 |
| Mycoplasma bovis-induced inhibition of bovine peripheral blood mononuclear cell proliferation is ameliorated after blocking the immune-inhibitory programmed death 1 receptor M Suleman, FS Cyprian, S Jimbo, T Maina, T Prysliak, C Windeyer, ... Infection and immunity 86 (3), 10.1128/iai. 00921-17, 2018 | 20 | 2018 |
HADI M. YASSINESection Head of Research, Associate Professor of Infectious Diseases, IBC chair, Qatar University在 QU.edu.qa 的电子邮件经过验证
